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Abstract
Background: Oral malignant melanoma (OMM) is an aggressive tumor with very low survival rate and easy to
metastasize. Pleural metastatic melanoma via primary OMM is rare.
Case presentation: In this report, we presented a case of metastatic malignant melanoma of the pleura originated
from OMM. A 54-year-old man without primary skin lesion was diagnosed multiple nodular shadows, pleural invasion,
and pleural effusion by chest computed tomography (CT). One cyst-form tumor on the tongue base was observed by
bronchoscopy, which was diagnosed as OMM by pathological examination and then was resected. After getting the
tumor tissues from the pleura by pleural biopsy surgery, the diagnosis of pathological examination was pleural
metastatic melanoma. Furthermore, tumor cells displayed a positive immunoreaction for melanocytic markers
S100 and HMB-45 combining with positive vimentin and cytokeratin AE1/AE3. The patient was therefore
diagnosed with metastatic melanoma of the left pleura and the primary melanoma was OMM.
Conclusions: According to this case, we could draw the conclusion that pleural metastasis from OMM was very rare
and thoracoscopy preceded under local anesthesia is an important method for its accurate diagnosis.
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Background
Melanomas, including two subtypes, are originated from
melanoblasts or melanocytes which can have a benign or
malignant clinical course. They mainly occur on the skin
and are relevant to ultraviolet light exposure as common
tumors in human [1]. The incidence of melanoma is in-
creasing about 5 % per year worldwide [2]. Malignant
melanoma (MM) is the most aggressive skin cancer ori-
ginating from melanocytes with a high degree of pheno-
typic plasticity, which is primarily located in the skin but
also found in eyes, ears, mouth, gastrointestinal tract,
genital mucosa, and leptomeninges [3]. Although melan-
oma accounts for only 5 % of all malignant skin tumors, it
has occupied 75 % deaths of all skin tumor patients [4].
Surgery can be performed as an effective treatment at the
early phase of the tumor. Unfortunately, melanoma is
prone to metastasis by lymphatic pathway to regional
lymph nodes and even by circulation to distant sites,
which can significantly worsen the prognosis [5, 6]. The
median survival time for metastatic melanoma patients is
only about 6–9 months [7, 8].
Primary melanoma of the thorax, which mainly involves
the lung and pleura, is exceptionally rare. In this report, we
presented a case that was diagnosed as metastatic MM of
the pleura by pleural biopsy surgery, which was originated
from an oral malignant melanoma (OMM). The initial
symptoms of this patient were chest pain and dyspnea for
2 months. Chest computed tomography (CT) which was
performed on a 64-row multidetector CT scanner
(Somatom Sensation, Siemens, Erlangen, Germany) showed
multiple nodular shadows, pleural invasion, and pleural
effusion, and at first, the case was misdiagnosed as lung
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Fig. 1 The chest CT imaging of the pleural effusion and lesions. Before operation, pleural effusion and lesions in the left thorax and multiple
metastases in the right lung can be seen in CT scan imaging (a and b). After complete drainage of pleural effusion, metastatic neoplasms in
pleura, enlargement of mediastinal lymph nodes, and lung metastases were clearly emerged by countercheck CT scan (c and d). The pleural
lesions were pointed by blue arrows in d. a and c Lung window. b and d Mediastinum window
Fig. 2 NBI bronchoscopy. One cystoma was on the left side of the tongue base (a). The cystoma was observed by bronchoscopy and pointed by
black arrows. Abnormalities were not seen in the glottis and tracheal juga (b and c). Bronchial stenosis of left pulmonary segments can be seen in d
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and pleural metastatic carcinoma. Therefore, thoracoscopy,
including video-assisted thoracoscopic surgery (VATS) and
simple rigid thoracoscopy, is the key to the accurate diag-
nosis of this disease.
Case presentation
The patient was a 54-year-old Han Chinese man who, in
June 2013, was diagnosed as double-sided pleural effusion
which was combined with the left multifocal pleural
lesions and multiple lung metastases in the right lung by
CT scan (Fig. 1a, b). The previous medical history reported
no primary skin lesion including melanin stain. The re-
lated examines were finished before thoracoscopy pleural
biopsy operation. One cyst of the neoplasm on the left side
of the tongue base and multiple bronchial stenosis of left
pulmonary segments were observed by narrow band im-
aging (NBI) bronchoscopy (Olympus, EVIS LUCERA)
(Fig. 2). The tumor was then resected and diagnosed as
OMM by pathological examination (Fig. 3a) and the
immunohistochemical staining results (Additional file 1:
Fig. 3 The pathological results of the resected tumor from the tongue base and pleural tumor tissue and immunohistochemical detection of the
pleural tumor tissue. The tissue’s histopathology changes were observed in light microscope (Nikon Eclipse 80i, Tokyo, Japan) and photos were taken.
Postoperative pathological results for the tongue base and pleural tumor tissue, respectively (a and b) (×200). The immunohistochemical results of the
pleural tumor tissue are shown in c–f, which are S100, HMB-45, vimentin, and cytokeratin AE1/AE3, respectively, and the magnification are all of ×100
Fig. 4 The semi-rigid thoracoscopy was used in pleural biopsy surgery
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Figure S1). The results of tuberculosis antibody (TB-Ab)
and TB-DNA in serum were all negative. Serum tumor
markers for lung carcinoma including carcino-embryonic
antigen, carbohydrate antigen 72-4, squamous cell carcin-
oma, cyfra 21-1, cytokeratin 19 fragments, and ferritin
were all in normal range. However, carbohydrate antigen
125 and neuron-specific enolase were about three times
and two times higher than the upper limits, respectively.
Subsequently, the pleural biopsy surgery of the left
thorax was preceded by semi-rigid thoracoscopy (model
LTF-240, Olympus, Tokyo, Japan) (Fig. 4) with video as-
sistance under local anesthesia using 10 mL 1 % Lidocaine
injected into the subcutaneous tissue. The thoracoscopy
was entered from a single port in the sixth intercostal
space. After extraction of 1500 mL bloody pleural fluid,
multiple violet black neoplasms can be seen in the parietal
pleura, which were different sizes, very brittle, and prone
to bleeding (Fig. 5). After biting from several sections of
these lesions, the tissues were used for pathological de-
tection. Pleural effusion was continuously discharged
by using closed drainage tube. Cytology examination of
pleural effusion displayed red blood cells in the field of
vision and severe abnormity of cell nucleus.
Postoperative pathological reports showed that these neo-
plasms were pleural metastatic melanoma by hematoxylin-
eosin (HE) staining, and combined immunohistochemical
results suggested that the HMB-45, S-100, vimentin, and
AE1/AE3 (antibodies were all purchased from Santa Cruz
Biotechnology (Santa Cruz, CA)) were all significantly
positive expressions (Fig. 3b–f ).
After almost complete drainage of pleural effusion, re-
markable multiple metastatic neoplasms in the pleura,
enlargement of mediastinal lymph nodes, and several
lung metastases could be clearly observed by counter-
check CT scan (Fig. 1c, d). During the inpatient period,
detections of brain CT scan, abdominal Doppler ultra-
sound, and so on, there were no evidence to confirm
other organs and any other lymphatic node metastases.
Subsequently, there was no further treatment, and less
than 6 months of follow-up, the patient died.
This case report and related experimental protocols
were approved by the ethics committee of Tianjin Union
Medicine Centre of China.
Discussion
In the past several decades, the incidence of melanoma has
been steadily rising with an annual increase of 3–8 %
worldwide [9]. The most common form of melanoma is
the cutaneous or the ocular form. As neural crest-derived
cells, melanocytes could migrate to the skin, mucous mem-
branes, and other sites. Melanoma metastasizing to thorax
is common, but primary pulmonary or pleural melanoma
Fig. 5 The main observation of pleural biopsy surgery in the right parietal pleura. Multiple violet-black neoplasms can be seen in the parietal
pleura by thoracoscopy with video assistance, being different sizes, very brittle, and prone to bleeding, and these lesions are pointed by white
arrows (a–c). d The tumor tissues were gained by biopsy forceps. The used forceps is pointed by blue arrow
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is extremely rare. Therefore, MM has very seldom been de-
scribed as a primary tumor in the pleura or lower respira-
tory tract, and there are only very limited literatures that
have been reported [10]. Since metastasis of MM to the
lung or pleura is relatively common, it is very important to
distinguish primary from secondary melanomas.
OMM, which was first described by Weber in 1859, is a
much rare neoplasm located at the basal layer of the oral
mucous membranes owing to the uncontrolled growth of
melanocytes [11]. Mucosal melanoma accounts for only
0.5 % of all oral tumor involving the sinonasal cavity, oral
cavity, pharynx, larynx, and upper esophagus [12]. Oral
melanomas occur slightly more often in males (2.8:1, male
to female ratio) and with an average age of 56 years (the
age range is from 20 to 83 years) [13]. OMM belongs to
head and neck mucosal melanomas (HNMM) and fre-
quently exhibits postoperative recurrence and distant
metastasis. For HNMM patients, surgery is recommended
if indicated, and surgery combined with postoperative
radiotherapy is also recommended for dramatically im-
proved local control of the tumor bed. Radiotherapy and
immunological therapy could be potential options for pa-
tients without surgery chance [14].
In the present case, the primary site of melanoma was
previously found in the root of the tongue without pri-
mary skin lesion. After obtaining the tumor tissues from
several sites of parietal pleura by pleural biopsy surgery,
the diagnosis of pathological examination was pleural
metastatic melanoma through HE staining method. Fur-
thermore, tumor cells displayed a positive immunoreac-
tion for melanocytic markers (S100 and HMB-45, which
are frequently expressed in primary oral melanomas and
helpful to confirm the diagnosis [15]). In addition, both
vimentin and cytokeratin AE1/AE3 also appeared as
positive expressions. We therefore ascertained that the
metastatic melanoma of the left pleura was metastasized
from OMM.
Modern thoracoscopy provides a potentially less inva-
sive means to diagnose and to treat a variety of intratho-
racic diseases. Simple rigid thoracoscopy or VATS is safe
and effective for the diagnosis of both benign and malig-
nant pleural disease which has very high sensitivity (80
to 100 %) [16]. For the present patient, the color and the
appearance of the melanoma are easy to recognize under
thoracoscopy, with the potential to limit complications
and to reduce morbidity and hospital stays for thoracot-
omy. Pleural tumorous diseases are one important indi-
cation for thoracoscopy with video assistance and can
easily be diagnosed accurately.
Conclusions
We have presented a very rare case of amelanotic mel-
anoma of the left parietal pleura that was diagnosed as
a metastatic tumor from OMM by detailed physical
examination and pathological and immunohistochemistry
detection. Pleural metastasis via OMM was very rare, and
thoracoscopy preceded under local anesthesia is an effect-
ive and safety method for its accurate diagnosis.
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The patient and his family members were informed and
have consented for the publication of this report. A copy
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Additional file 1: Figure S1. The immunohistochemical results of the
primary tongue melanoma tissue are shown in (a), (b), (c) and (d), which
are S100, HMB-45, vimentin, and cytokeratin AE1/AE3, respectively, and
the magnification are all of ×200 (JPG 2042 kb)
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